Abstract:Introduction Release and insufficient removal of endogenous nucleic acids may be involved in triggering autoimmune reactions important in the initiation of systemic autoimmune diseases including rheumatoid arthritis (RA). Nucleic acid sensing molecules, such as the endosomal Toll-like receptors (TLRs) 7 and 9, have been linked to pathogenic autoimmune processes, but their role in RA is less clear. Objectives To gain more insight into the role of TLR9 in autoimmune arthritis, TLR9 inhibition was investigated in rats with pristane-induced arthritis (PIA). To further investigate TLR9 involvement, streptococcal cell wall (SCW) arthritis was induced in TLR9-/- mice. Methods Arthritis was induced in mice with SCW lysates and in rats with the mineral oil pristane. Rats were treated with a TLR9 antagonist, starting before disease induction. Arthritis was scored using established scoring systems, inflammation and bone erosion was quantified by histological analysis of the paws. Levels of α−1-acid-glycoprotein (AGP), rheumatoid factor (RF) and IL-6 in sera were analysed. The role of TLR9 in osteoclast differentiation was investigated in vitro. Results In PIA, which is T cell-dependent, the TLR9 antagonist reduced arthritis severity by ~50%. This was accompanied by a reduction of AGP, IL-6 and RF in the sera of these animals. In addition, TLR9 inhibition led to reduced inflammation, bone erosion and cartilage degradation in the paws. Moreover, the T cell-dependent chronic phase of SCW arthritis was significantly suppressed in TLR9-/- mice. Remarkably, TLR7 and TLR9 mRNA levels strongly differed in the course of in vitro osteoclastogenesis. Whereas TLR7 expression did not change throughout osteoclastogenesis, expression of TLR9 was higher in precursor cells than in mature osteoclasts and stimulation with a TLR9 agonist (CpG) completely inhibited osteoclastogenesis. Conclusions The results suggest a crucial role for TLR9 in the T cell-dependent phases of PIA and SCW arthritis and thus an important involvement of the DNA (CpG) recognising TLR9 in the induction of arthritogenic autoimmune reactions. In addition, TLR9 also seems to play a role in the initiation of osteoclast differentiation which needs to be further elucidated in future experiments. Disclosure of interest None declared

Toll-like Receptors Are Potential Therapeutic Targets in Rheumatoid Arthritis

Toll-like Receptors As Therapeutic Targets for Autoimmune Connective Tissue Diseases.

Therapeutic Potential of Non-Coding RNAs and TLR Signalling Pathways in Rheumatoid Arthritis

Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease

Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

Toll-like Receptors Expressed by Synovial Fibroblasts Perpetuate Th1 and Th17 Cell Responses in Rheumatoid Arthritis.

Sphingosine-1-phosphate: a Potential Therapeutic Target for Rheumatoid Arthritis

Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis

The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis.

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis

Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics

P020 Toll-like Receptor 9 Influences Inflammatory Arthritis and Osteoclastogenesis

Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

Signaling pathways in rheumatoid arthritis: implications for targeted therapy

The role of TNF-α and its receptors in rheumatoid arthritis

Toll-Like Receptors: Role in Dermatological Disease